These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10499558)

  • 1. Angiotensin converting enzyme inhibitors and vascular protection in hypertension.
    Ruschitzka F; Noll G; Lüscher TF
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 1():S3-12. PubMed ID: 10499558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular protection: current possibilities and future perspectives.
    Lüscher TF
    Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endothelium in coronary artery disease.
    Ruschitzka FT; Noll G; Lüscher TF
    Cardiology; 1997; 88 Suppl 3():3-19. PubMed ID: 9397288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F; Hürlimann D; Lüscher TF
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
    Ruschitzka FT; Lüscher TF
    Am Heart J; 1997 Aug; 134(2 Pt 2):S31-47. PubMed ID: 9313622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone.
    Lüscher TF
    Basic Res Cardiol; 1993; 88 Suppl 1():15-24. PubMed ID: 8357330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial function and bradykinin in humans.
    Hornig B; Drexler H
    Drugs; 1997; 54 Suppl 5():42-7. PubMed ID: 9429844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle.
    Lüscher TF; Yang Z
    Drugs; 1993; 46 Suppl 2():121-32. PubMed ID: 7512465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide.
    Mombouli JV
    Drugs; 1997; 54 Suppl 5():12-22. PubMed ID: 9429841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
    Hornig B; Arakawa N; Drexler H
    Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endothelium in acute coronary syndromes.
    Noll G; Lüscher TF
    Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type I receptor blocker and endothelial function in humans: role of nitric oxide and oxidative stress.
    Higashi Y; Chayama K; Yoshizumi M
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):133-48. PubMed ID: 15853700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-dependent effects of converting-enzyme inhibitors.
    Vanhoutte PM; Boulanger CM; Illiano SC; Nagao T; Vidal M; Mombouli JV
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S10-6. PubMed ID: 7508046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction: from physiology to therapy.
    Mombouli JV; Vanhoutte PM
    J Mol Cell Cardiol; 1999 Jan; 31(1):61-74. PubMed ID: 10072716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide.
    Gibbons GH
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-18-25. PubMed ID: 9422848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium-dependent responses and inhibition of angiotensin-converting enzyme.
    Vanhoutte PM
    Clin Exp Pharmacol Physiol; 1996 Aug; 23(8):S23-9. PubMed ID: 8886509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of ACE inhibitors and calcium antagonists: a logical approach.
    Ruschitzka FT; Noll G; Lüscher TF
    J Cardiovasc Pharmacol; 1998; 31 Suppl 2():S5-16. PubMed ID: 9605596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of the endothelium in the control of vascular motility: physiologic aspects and physiopathologic implications in cardiovascular diseases].
    Limone P; Boeri E; Molinatti GM
    Minerva Med; 1993 Oct; 84(10):499-505. PubMed ID: 8247303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.